Skip to content

Exploring the efficacy of dual-target rTMS treatment in the M1 region of the brain combined with cerebellar dual-target rTMS on post-stroke dysphagia

Exploring the efficacy of dual-target rTMS treatment in the M1 region of the brain combined with cerebellar dual-target rTMS on post-stroke dysphagia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400086638
Enrollment
Unknown
Registered
2024-07-08
Start date
2024-07-10
Completion date
Unknown
Last updated
2024-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Cerebral group (G1):Repetitive transcranial magnetic stimulation
Cerebellar group (G2):Repetitive transcranial magnetic stimulation
Combined group (G3):Repetitive transcranial magnetic stimulation

Sponsors

Department of Rehabilitation Medicine, The First Affiliated Hospital of Gannan Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: (1) Age =18 years old, gender is not limited; (2) Patients with stroke diagnosed by computed tomography/magnetic resonance confirmed in accordance with the diagnostic criteria for stroke established by the Fourth National Academic Conference on Cerebrovascular Disease; (3) Clinical manifestations such as choking on drinking water and difficulty in swallowing, etc., confirmed by swallowing imaging as impaired oropharyngeal swallowing efficiency or safety; (4) Duration of dysphagia > 2 weeks; (5) Patients or their immediate family members voluntarily participated in this study and signed an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Suffering from serious diseases of the heart, liver or kidney and unstable vital signs; (2) Pregnant or lactating women; (3) Patients with swallowing disorders secondary to other diseases; (4) Patients with a history of epilepsy; (5) Patients with tracheotomy or tracheal intubation; (6) Contraindications to transcranial magnetic stimulation therapy such as having intracranial metal built-in objects, excessive intracranial pressure, etc; (7) Those who were participating in other clinical studies or had participated in other clinical studies within 3 months before admission; (8) Patients with poor compliance; (9) Other patients deemed unsuitable for enrolment by the investigator.

Design outcomes

Primary

MeasureTime frame
Functional Oral Intake Scale (FOIS);Functional Near Infrared Spectroscopy Scanning (fNIRS);

Secondary

MeasureTime frame
Classification of drinking water for puddle fields;Clinical Dysphagia Score (CDS);Dysphagia Outcome and Severity Scale (DOSS);Permeation Aspiration Score (PAS);Modified Bathel Index;

Countries

China

Contacts

Public ContactLuo Yun

Department of Rehabilitation Medicine, The First Affiliated Hospital of Gannan Medical University

1146889587@qq.com+86 157 5430 6145

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026